BIO Asia–Taiwan 2022 亞洲生技大會

BIO Asia–Taiwan 2022 亞洲生技大會

TEACHER

Ming-Kuei Jang

Session 8 – Healthcare Innovation Strategy

Date:28 July (Thursday)
Time:  12:20 – 13:50 (GMT+8)

Ming-Kuei Jang

CEO
APRINOIA Therapeutics Inc.

.​

Alzheimer drug discovery consortium, MD Anderson Cancer Center, Houston

Associate Director, GlaxoSmithKline, Shanghai

Senior Research Biologist, Merck & CO, Boston

Postdoc in Neurophysiology at Northwestern University and Columbia University

Ph.D in Pharmacology and Neuroscience, Boston University

BS in Chemistry, National Taiwan University, Taiwan

Neurodegenerative diseases; synaptic functions; novel biomarker discovery
 

Speech title & Synopsis

Panel Discussion: Accelerating Innovation Through External Collaboration

.